Global Next-Generation Drug-Eluting Stent Market Insights, Forecast to 2025

Publisher Name :
Date: 10-May-2019
No. of pages: 115
Inquire Before Buying

Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.

The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.

The global Next-Generation Drug-Eluting Stent market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Next-Generation Drug-Eluting Stent market based on company, product type, end user and key regions.

This report studies the global market size of Next-Generation Drug-Eluting Stent in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Next-Generation Drug-Eluting Stent in these regions.

This research report categorizes the global Next-Generation Drug-Eluting Stent market by top players/brands, region, type and end user. This report also studies the global Next-Generation Drug-Eluting Stent market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Abbott

- Biosensors International

- Medtronic

- Sorin Group

- SMT

- Terumo

Market size by Product

- Cobalt Chromium

- Stainless Steel

- Others

Market size by End User

- Hospitals

- Clinics

- Ambulatory Surgical Centers

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Next-Generation Drug-Eluting Stent market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Next-Generation Drug-Eluting Stent market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Next-Generation Drug-Eluting Stent companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Next-Generation Drug-Eluting Stent submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Next-Generation Drug-Eluting Stent are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Next-Generation Drug-Eluting Stent market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Next-Generation Drug-Eluting Stent Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Next-Generation Drug-Eluting Stent Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Product
1.4.2 Cobalt Chromium
1.4.3 Stainless Steel
1.4.4 Others
1.5 Market by End User
1.5.1 Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Next-Generation Drug-Eluting Stent Market Size
2.1.1 Global Next-Generation Drug-Eluting Stent Revenue 2014-2025
2.1.2 Global Next-Generation Drug-Eluting Stent Sales 2014-2025
2.2 Next-Generation Drug-Eluting Stent Growth Rate by Regions
2.2.1 Global Next-Generation Drug-Eluting Stent Sales by Regions
2.2.2 Global Next-Generation Drug-Eluting Stent Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Next-Generation Drug-Eluting Stent Sales by Manufacturers
3.1.1 Next-Generation Drug-Eluting Stent Sales by Manufacturers
3.1.2 Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers
3.1.3 Global Next-Generation Drug-Eluting Stent Market Concentration Ratio (CR5 and HHI)
3.2 Next-Generation Drug-Eluting Stent Revenue by Manufacturers
3.2.1 Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2014-2019)
3.2.2 Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2014-2019)
3.3 Next-Generation Drug-Eluting Stent Price by Manufacturers
3.4 Next-Generation Drug-Eluting Stent Manufacturing Base Distribution, Product Types
3.4.1 Next-Generation Drug-Eluting Stent Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Next-Generation Drug-Eluting Stent Product Type
3.4.3 Date of International Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Next-Generation Drug-Eluting Stent Sales by Product
4.2 Global Next-Generation Drug-Eluting Stent Revenue by Product
4.3 Next-Generation Drug-Eluting Stent Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Next-Generation Drug-Eluting Stent Breakdown Data by End User
6 North America
6.1 North America Next-Generation Drug-Eluting Stent by Countries
6.1.1 North America Next-Generation Drug-Eluting Stent Sales by Countries
6.1.2 North America Next-Generation Drug-Eluting Stent Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Next-Generation Drug-Eluting Stent by Product
6.3 North America Next-Generation Drug-Eluting Stent by End User
7 Europe
7.1 Europe Next-Generation Drug-Eluting Stent by Countries
7.1.1 Europe Next-Generation Drug-Eluting Stent Sales by Countries
7.1.2 Europe Next-Generation Drug-Eluting Stent Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Next-Generation Drug-Eluting Stent by Product
7.3 Europe Next-Generation Drug-Eluting Stent by End User
8 Asia Pacific
8.1 Asia Pacific Next-Generation Drug-Eluting Stent by Countries
8.1.1 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Countries
8.1.2 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Next-Generation Drug-Eluting Stent by Product
8.3 Asia Pacific Next-Generation Drug-Eluting Stent by End User
9 Central & South America
9.1 Central & South America Next-Generation Drug-Eluting Stent by Countries
9.1.1 Central & South America Next-Generation Drug-Eluting Stent Sales by Countries
9.1.2 Central & South America Next-Generation Drug-Eluting Stent Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Next-Generation Drug-Eluting Stent by Product
9.3 Central & South America Next-Generation Drug-Eluting Stent by End User
10 Middle East and Africa
10.1 Middle East and Africa Next-Generation Drug-Eluting Stent by Countries
10.1.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Countries
10.1.2 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Next-Generation Drug-Eluting Stent by Product
10.3 Middle East and Africa Next-Generation Drug-Eluting Stent by End User
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Next-Generation Drug-Eluting Stent Products Offered
11.1.5 Abbott Recent Development
11.2 Biosensors International
11.2.1 Biosensors International Company Details
11.2.2 Company Business Overview
11.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Biosensors International Next-Generation Drug-Eluting Stent Products Offered
11.2.5 Biosensors International Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Company Business Overview
11.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Medtronic Next-Generation Drug-Eluting Stent Products Offered
11.3.5 Medtronic Recent Development
11.4 Sorin Group
11.4.1 Sorin Group Company Details
11.4.2 Company Business Overview
11.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sorin Group Next-Generation Drug-Eluting Stent Products Offered
11.4.5 Sorin Group Recent Development
11.5 SMT
11.5.1 SMT Company Details
11.5.2 Company Business Overview
11.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
11.5.4 SMT Next-Generation Drug-Eluting Stent Products Offered
11.5.5 SMT Recent Development
11.6 Terumo
11.6.1 Terumo Company Details
11.6.2 Company Business Overview
11.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Terumo Next-Generation Drug-Eluting Stent Products Offered
11.6.5 Terumo Recent Development
12 Future Forecast
12.1 Next-Generation Drug-Eluting Stent Market Forecast by Regions
12.1.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Regions 2019-2025
12.1.2 Global Next-Generation Drug-Eluting Stent Revenue Forecast by Regions 2019-2025
12.2 Next-Generation Drug-Eluting Stent Market Forecast by Product
12.2.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Product 2019-2025
12.2.2 Global Next-Generation Drug-Eluting Stent Revenue Forecast by Product 2019-2025
12.3 Next-Generation Drug-Eluting Stent Market Forecast by End User
12.4 North America Next-Generation Drug-Eluting Stent Forecast
12.5 Europe Next-Generation Drug-Eluting Stent Forecast
12.6 Asia Pacific Next-Generation Drug-Eluting Stent Forecast
12.7 Central & South America Next-Generation Drug-Eluting Stent Forecast
12.8 Middle East and Africa Next-Generation Drug-Eluting Stent Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Next-Generation Drug-Eluting Stent Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Next-Generation Drug-Eluting Stent Product Picture
Table Next-Generation Drug-Eluting Stent Market Segments
Table Key Manufacturers Next-Generation Drug-Eluting Stent Covered
Table Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Product 2014-2025
Figure Cobalt Chromium Product Picture
Table Major Manufacturers of Cobalt Chromium
Figure Stainless Steel Product Picture
Table Major Manufacturers of Stainless Steel
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Next-Generation Drug-Eluting Stent Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Ambulatory Surgical Centers
Figure Next-Generation Drug-Eluting Stent Report Years Considered
Figure Global Next-Generation Drug-Eluting Stent Market Size 2014-2025 (Million US$)
Figure Global Next-Generation Drug-Eluting Stent Sales 2014-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Next-Generation Drug-Eluting Stent Sales by Regions 2014-2019 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share by Regions 2014-2019
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Regions 2014-2019
Figure 2018 Global Next-Generation Drug-Eluting Stent Sales Market Share by Regions
Table Global Next-Generation Drug-Eluting Stent Revenue by Regions 2014-2019 (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions 2014-2019
Figure Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions 2014-2019
Figure 2018 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Regions
Table Global Next-Generation Drug-Eluting Stent Sales by Manufacturers (2014-2019) (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Share by Manufacturers (2014-2019)
Figure Global Next-Generation Drug-Eluting Stent Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Next-Generation Drug-Eluting Stent Revenue by Manufacturers (2014-2019) (Million USD)
Table Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2014-2019)
Figure Next-Generation Drug-Eluting Stent Value Share by Manufacturers in 2018
Table Key Manufacturers Next-Generation Drug-Eluting Stent Price (2014-2019) (USD/Unit)
Table Next-Generation Drug-Eluting Stent Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Next-Generation Drug-Eluting Stent Product Type
Table Date of International Manufacturers Enter into Next-Generation Drug-Eluting Stent Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Next-Generation Drug-Eluting Stent Sales by Product (2014-2019) (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Share by Product (2014-2019)
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Product (2014-2019)
Figure Global Next-Generation Drug-Eluting Stent Sales Market Share by Product in 2018
Table Global Next-Generation Drug-Eluting Stent Revenue by Product (2014-2019) (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Share by Product (2014-2019)
Figure Global Next-Generation Drug-Eluting Stent Revenue Market Share by Product (2014-2019)
Figure Global Next-Generation Drug-Eluting Stent Revenue Market Share by Product in 2018
Table Next-Generation Drug-Eluting Stent Price by Product 2014-2019 (USD/Unit)
Table Global Next-Generation Drug-Eluting Stent Sales by End User (2014-2019) (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Share by End User (2014-2019)
Figure Global Sales Next-Generation Drug-Eluting Stent Market Share by End User (2014-2019)
Figure Global Sales Next-Generation Drug-Eluting Stent Market Share by End User in 2018
Figure North America Next-Generation Drug-Eluting Stent Sales Growth Rate 2014-2019 (K Units)
Figure North America Next-Generation Drug-Eluting Stent Revenue Growth Rate 2014-2019 (Million US$)
Table North America Next-Generation Drug-Eluting Stent Sales by Countries (2014-2019) (K Units)
Table North America Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2014-2019)
Figure 2018 North America Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table North America Next-Generation Drug-Eluting Stent Revenue by Countries (2014-2019) (Million US$)
Table North America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure United States Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure United States Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Canada Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Table North America Next-Generation Drug-Eluting Stent Sales by Product (2014-2019) (K Units)
Table North America Next-Generation Drug-Eluting Stent Sales Market Share by Product (2014-2019)
Figure 2018 North America Next-Generation Drug-Eluting Stent Market Share by Product
Table North America Next-Generation Drug-Eluting Stent Sales by End User (2014-2019) (K Units)
Table North America Next-Generation Drug-Eluting Stent Sales Market Share by End User (2014-2019)
Figure 2018 North America Next-Generation Drug-Eluting Stent Market Share by End User
Figure Europe Next-Generation Drug-Eluting Stent Sales Growth Rate 2014-2019 (K Units)
Figure Europe Next-Generation Drug-Eluting Stent Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Next-Generation Drug-Eluting Stent Sales by Countries (2014-2019) (K Units)
Table Europe Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Europe Next-Generation Drug-Eluting Stent Revenue by Countries (2014-2019) (Million US$)
Table Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure Germany Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Germany Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure France Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure France Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure UK Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Italy Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Russia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Next-Generation Drug-Eluting Stent Sales by Product (2014-2019) (K Units)
Table Europe Next-Generation Drug-Eluting Stent Sales Market Share by Product (2014-2019)
Figure 2018 Europe Next-Generation Drug-Eluting Stent Market Share by Product
Table Europe Next-Generation Drug-Eluting Stent Sales by End User (2014-2019) (K Units)
Table Europe Next-Generation Drug-Eluting Stent Sales Market Share by End User (2014-2019)
Figure 2018 Europe Next-Generation Drug-Eluting Stent Market Share by End User
Figure Asia Pacific Next-Generation Drug-Eluting Stent Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Next-Generation Drug-Eluting Stent Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure China Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure China Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Japan Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Korea Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure India Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure India Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Australia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales by Product (2014-2019) (K Units)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Next-Generation Drug-Eluting Stent Market Share by Product
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales by End User (2014-2019) (K Units)
Table Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Next-Generation Drug-Eluting Stent Market Share by End User
Figure Central & South America Next-Generation Drug-Eluting Stent Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Next-Generation Drug-Eluting Stent Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Next-Generation Drug-Eluting Stent Sales by Countries (2014-2019) (K Units)
Table Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Central & South America Next-Generation Drug-Eluting Stent Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure Brazil Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Next-Generation Drug-Eluting Stent Sales by Product (2014-2019) (K Units)
Table Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Next-Generation Drug-Eluting Stent Market Share by Product
Table Central & South America Next-Generation Drug-Eluting Stent Sales by End User (2014-2019) (K Units)
Table Central & South America Next-Generation Drug-Eluting Stent Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Next-Generation Drug-Eluting Stent Market Share by End User
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Countries
Table Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Countries
Figure GCC Countries Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Next-Generation Drug-Eluting Stent Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Next-Generation Drug-Eluting Stent Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Next-Generation Drug-Eluting Stent Market Share by Product
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Next-Generation Drug-Eluting Stent Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Next-Generation Drug-Eluting Stent Market Share by End User
Table Abbott Company Details
Table Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table Biosensors International Company Details
Table Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biosensors International Recent Development
Table Medtronic Company Details
Table Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medtronic Recent Development
Table Sorin Group Company Details
Table Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sorin Group Recent Development
Table SMT Company Details
Table SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table SMT Recent Development
Table Terumo Company Details
Table Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Terumo Recent Development
Table Global Next-Generation Drug-Eluting Stent Sales Forecast by Regions 2019-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Regions 2019-2025
Table Global Next-Generation Drug-Eluting Stent Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Regions 2019-2025
Table Global Next-Generation Drug-Eluting Stent Sales Forecast by Product 2019-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by Product 2019-2025
Table Global Next-Generation Drug-Eluting Stent Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Next-Generation Drug-Eluting Stent Revenue Market Share Forecast by Product 2019-2025
Table Global Next-Generation Drug-Eluting Stent Sales Forecast by End User 2019-2025 (K Units)
Table Global Next-Generation Drug-Eluting Stent Sales Market Share Forecast by End User 2019-2025
Figure North America Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Next-Generation Drug-Eluting Stent Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Next-Generation Drug-Eluting Stent Value Chain
Table Next-Generation Drug-Eluting Stent Customers List
Table Next-Generation Drug-Eluting Stent Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global PERS Devices Market Growth 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 166
    According to this study, over the next five years the PERS Devices market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in PERS Devices business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of PERS Devices market by type, application, key ma......
  • Global Handheld Slit Lamp Market Growth 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 159
    According to this study, over the next five years the Handheld Slit Lamp market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Handheld Slit Lamp business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Handheld Slit Lamp market by type, a......
  • Global Peripheral Wires Market Growth 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the Peripheral Wires market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Peripheral Wires business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Wires market by type, applica......
  • Global IR Thermometers Market Growth 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 163
    According to this study, over the next five years the IR Thermometers market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in IR Thermometers business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of IR Thermometers market by type, applicatio......
  • Global Medical Duodenal Stent Market Growth 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 161
    According to this study, over the next five years the Medical Duodenal Stent market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Duodenal Stent business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Duodenal Stent marke......
  • Global Medical Copper Tubes Market Growth 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 164
    According to this study, over the next five years the Medical Copper Tubes market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Copper Tubes business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Copper Tubes market by t......
  • Global Intravascular Stent Market Growth 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 130
    According to this study, over the next five years the Intravascular Stent market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Intravascular Stent business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Intravascular Stent market by type......
  • Global Oncolytic Virus Cancer Immunotherapy Market Growth (Status and Outlook) 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Oncolytic Virus Cancer Immunotherapy market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Oncolytic Virus Cancer Immunotherapy business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of Oncolytic Vir......
  • Global Organ Transplant Anti-rejection Medications Market Growth (Status and Outlook) 2020-2025
    Published: 03-Apr-2020        Price: US 3660 Onwards        Pages: 118
    According to this study, over the next five years the Organ Transplant Anti-rejection Medications market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Organ Transplant Anti-rejection Medications business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs